Długoterminowe wyniki kliniczne zmodyfikowanej operacji usunięcia półkuli mózgowej w leczeniu opornej epilepsji: seria przypadków i przegląd systematyczny

PubMed➕ 18.09.2026Clin Neurol Neurosurg

Long-term clinical outcomes of the Adams modification to the anatomical hemispherectomy for refractory epilepsy: A case series and global systematic review

W skrócie

Badanie analizuje wyniki operacji chirurgicznej polegającej na usunięciu połowy mózgu u pacjentów z oporną na leki epilepsją. U większości pacjentów (63%) uzyskano brak napadów w ciągu pięciu lat po zabiegu, a u 80% z nich stan ten utrzymywał się długoterminowo. Poprawa w funkcjonowaniu neurologicznym i zachowaniu pacjentów obserwowana była odpowiednio u 69% i 80% chorych, choć jeden trzeci pacjentów doświadczył powikłań pooperacyjnych.

Oryginalny abstract (angielski)

BACKGROUND: Although contemporary hemispheric epilepsy surgery has largely shifted towards functional disconnection and hemispherotomy, complete anatomical approaches may retain a role in selected patients, including as rescue procedures after failed disconnection. In the 1980s, a modified anatomical hemispherectomy was developed at the Radcliffe Infirmary at the University of Oxford, incorporating an extended extradural dissection to reduce delayed haemorrhagic complications. The long-term efficacy of this approach in refractory epilepsy and related comorbidities has not previously been evaluated. METHODS: We performed a retrospective observational study and systematic review. Clinical data were obtained from patients undergoing modified hemispherectomy at our institution between 1983 and 1996. A systematic search of MEDLINE, EMBASE, and Scopus (inception-December 2024) was conducted according to PRISMA guidelines. Studies including ≥ 10 patients with postoperative seizure outcomes reported after ≥ 5 years' mean or median follow-up were included. Epilepsy aetiology and surgical techniques were categorised using predefined criteria. Outcomes focused on seizure freedom at final follow-up, complications and neurocognitive outcomes were reported. Statistical analyses employed parametric or non-parametric testing with significance set at p ≤ 0.05. RESULTS: In our patient cohort (n = 49), most patients presented with focal onset seizures with secondary generalisation (59%) and an acquired aetiology (65%). Within five years of surgery, 63% achieved seizure freedom. Anti-seizure medications were discontinued in 51%, of whom 80% remained seizure-free at long-term follow-up. Neurodevelopmental improvement was observed in 69% and behavioural improvement in 80% of individuals. Seizure freedom was significantly associated with gains in neurocognitive (OR 9.6, 95%:CI 2.36-32.70) and behavioural (OR 6.5, 95%:CI 1.48-25.59) outcomes. Postoperative complications occurred in 16 patients (33%), more than half of which were wound infections (9, 56%). The systematic review included 58 studies, 77% from high-income countries, and demonstrated a median seizure freedom rate of 74% at last follow-up (median 5.7 years, IQR 5.1-7.0), with functional hemispherectomies showing superior outcomes. CONCLUSIONS: This study presents the largest systematic review of hemispherectomies to date and provides new insight into a surgical modification that influenced the evolution of modern epilepsy surgery.

Metadane publikacji

Journal
Clin Neurol Neurosurg
Data publikacji
27.08.2026
PMID
42753674
DOI
10.1016/j.clineuro.2026.109629
Autorzy
Burman RJ, Himic V, Mathy A, Lockwood E, Ni H, Sen A
Słowa kluczowe
Epilepsy surgery, Global epilepsy, Hemispherectomy, Neurocognitive outcomes, Paediatric epileptology
Źródło
PubMed